US Stock MarketDetailed Quotes

ADGM Adagio Medical

Watchlist
  • 2.670
  • +0.120+4.71%
Close Nov 29 13:00 ET
  • 2.631
  • -0.039-1.46%
Post 17:01 ET
38.81MMarket Cap-895P/E (TTM)

Adagio Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
-56.67%26K
58.73%300K
78K
41K
60K
-30.00%189K
0
270K
Operating revenue
----
-56.67%26K
58.73%300K
--78K
--41K
--60K
-30.00%189K
--0
--270K
Cost of revenue
70.44%542K
49.26%1.31M
14.78%334K
253K
318K
-24.44%875K
291K
1.16M
Gross profit
-100.00%-516K
-46.65%-1.01M
12.03%-256K
-212K
-258K
22.75%-686K
-291K
-888K
Operating expense
29.75%8.3M
15.97%26.94M
-14.20%5.08M
8.87M
6.4M
17.56%23.23M
5.92M
19.76M
Selling and administrative expenses
----
202.25%4.83M
114.76%11.54M
125.77%3.3M
--4.45M
--1.6M
22.04%5.37M
--1.46M
--4.4M
Research and development costs
----
-27.70%3.47M
-13.76%15.4M
-60.17%1.77M
--4.42M
--4.8M
16.28%17.86M
--4.45M
--15.36M
Operating profit
-32.48%-8.82M
-16.85%-27.94M
14.09%-5.33M
-9.08M
-6.65M
-15.83%-23.91M
-6.21M
-20.65M
Net non-operating interest income expense
-224.57%-753K
-1,589.80%-1.66M
-333.08%-576K
-483K
-232K
-3,366.67%-98K
-133K
3K
Non-operating interest income
----
0.00%1K
-92.31%3K
-75.00%1K
--2K
--1K
1,200.00%39K
--4K
--3K
Non-operating interest expense
----
223.61%754K
1,110.95%1.66M
321.17%577K
--485K
--233K
--137K
--137K
--0
Other net income (expense)
164.85%1.55M
-2,628.99%-8.55M
-1,481.23%-4.27M
-1.2M
-2.39M
-51.99%338K
309K
704K
Gain on sale of security
----
166.54%1.59M
---8.53M
---4.36M
---1.07M
---2.39M
----
----
----
Special income (charges)
----
----
----
----
----
----
----
----
--744K
-Less:Other special charges
----
----
----
----
----
----
----
----
---744K
Other non- operating income (expenses)
----
-1,175.00%-43K
-105.92%-20K
-69.90%93K
---123K
--4K
945.00%338K
--309K
---40K
Income before tax
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
-10.76M
-9.28M
-18.73%-23.67M
-6.03M
-19.94M
Income tax
Net income
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
-10.76M
-9.28M
-18.73%-23.67M
-6.03M
-19.94M
Net income continuous Operations
----
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
---10.76M
---9.28M
-18.73%-23.67M
---6.03M
---19.94M
Minority interest income
Net income attributable to the parent company
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
-10.76M
-9.28M
-18.73%-23.67M
-6.03M
-19.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.56%-8.02M
-61.14%-38.15M
-68.72%-10.18M
-10.76M
-9.28M
-18.73%-23.67M
-6.03M
-19.94M
Basic earnings per share
13.56%-0.5989
-61.14%-2.8493
-68.72%-0.7602
-0.8038
-0.6929
-18.73%-1.7683
-0.4506
-1.4893
Diluted earnings per share
13.56%-0.5989
-61.14%-2.8493
-68.72%-0.7602
-0.8038
-0.6929
-18.73%-1.7683
-0.4506
-1.4893
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
Unqualified Opinion with Explanatory Notes
(Q3)Sep 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Total revenue -56.67%26K58.73%300K78K41K60K-30.00%189K0270K
Operating revenue -----56.67%26K58.73%300K--78K--41K--60K-30.00%189K--0--270K
Cost of revenue 70.44%542K49.26%1.31M14.78%334K253K318K-24.44%875K291K1.16M
Gross profit -100.00%-516K-46.65%-1.01M12.03%-256K-212K-258K22.75%-686K-291K-888K
Operating expense 29.75%8.3M15.97%26.94M-14.20%5.08M8.87M6.4M17.56%23.23M5.92M19.76M
Selling and administrative expenses ----202.25%4.83M114.76%11.54M125.77%3.3M--4.45M--1.6M22.04%5.37M--1.46M--4.4M
Research and development costs -----27.70%3.47M-13.76%15.4M-60.17%1.77M--4.42M--4.8M16.28%17.86M--4.45M--15.36M
Operating profit -32.48%-8.82M-16.85%-27.94M14.09%-5.33M-9.08M-6.65M-15.83%-23.91M-6.21M-20.65M
Net non-operating interest income expense -224.57%-753K-1,589.80%-1.66M-333.08%-576K-483K-232K-3,366.67%-98K-133K3K
Non-operating interest income ----0.00%1K-92.31%3K-75.00%1K--2K--1K1,200.00%39K--4K--3K
Non-operating interest expense ----223.61%754K1,110.95%1.66M321.17%577K--485K--233K--137K--137K--0
Other net income (expense) 164.85%1.55M-2,628.99%-8.55M-1,481.23%-4.27M-1.2M-2.39M-51.99%338K309K704K
Gain on sale of security ----166.54%1.59M---8.53M---4.36M---1.07M---2.39M------------
Special income (charges) ----------------------------------744K
-Less:Other special charges -----------------------------------744K
Other non- operating income (expenses) -----1,175.00%-43K-105.92%-20K-69.90%93K---123K--4K945.00%338K--309K---40K
Income before tax 13.56%-8.02M-61.14%-38.15M-68.72%-10.18M-10.76M-9.28M-18.73%-23.67M-6.03M-19.94M
Income tax
Net income 13.56%-8.02M-61.14%-38.15M-68.72%-10.18M-10.76M-9.28M-18.73%-23.67M-6.03M-19.94M
Net income continuous Operations ----13.56%-8.02M-61.14%-38.15M-68.72%-10.18M---10.76M---9.28M-18.73%-23.67M---6.03M---19.94M
Minority interest income
Net income attributable to the parent company 13.56%-8.02M-61.14%-38.15M-68.72%-10.18M-10.76M-9.28M-18.73%-23.67M-6.03M-19.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.56%-8.02M-61.14%-38.15M-68.72%-10.18M-10.76M-9.28M-18.73%-23.67M-6.03M-19.94M
Basic earnings per share 13.56%-0.5989-61.14%-2.8493-68.72%-0.7602-0.8038-0.6929-18.73%-1.7683-0.4506-1.4893
Diluted earnings per share 13.56%-0.5989-61.14%-2.8493-68.72%-0.7602-0.8038-0.6929-18.73%-1.7683-0.4506-1.4893
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------------Unqualified Opinion with Explanatory Notes--Unqualified Opinion with Explanatory Notes

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data